Epidemiology Expert Witnesses

Epidemiology expert witnesses and consultants listed here may be able to form expert opinions, draft expert witness reports, provide expert witness testimony at deposition and/or trial as or serve as consulting (non-testifying) experts on epidemiology. The epidemiology expert witness listings on this page are typically from fields/areas of expertise such as: Addiction Medicine, Cardiovascular Disease, Infectious Diseases, Occupational Medicine, Pediatric Infectious Diseases, Pharmaceutical Research, Preventive Medicine, Public Health, and Toxicology.

Michael Fischman, MD, MPH Michael L. Fischman, M.D., APC

Walnut Creek, California
Toxicology, Occupational Medicine - Mold, Carbon monoxide toxicity, benzene toxicity, cancer causation, occupational/environmental lung diseases, metals toxicity, indoor air quality/building associated illness, epidemiology, epidemiology (cancer), inhalation toxicity
Clinical Professor, Division of Occupational & Environmental Medicine, University of California San Francisco Consultant, Fischman Occupational & Environmental Medical Group Diplomate, American Board of Preventive Medicine in Occupational Medicine Diplomate, American Board of Internal Medicine Medical-legal consultant and expert witness in Occupational & Environmental Medicine and Toxicology Fellow, American College of Occupational and Environmental Medicine (ACOEM) Member, Board of Directors, American College of Occupational & Environmental Medicine (ACOEM), 2009 - 2015 Chair, ACOEM Council of Scientific Advisors, 2010-present Co-author, "Chemical Hazards of the Workplace", Van Nostrand Reinhold, 1991, among others. Co-author “Occupational Cancer ”,Current Occupational & Environmental Medicine, Ed.: J La Dou and R Harrison. Fifth Edition, New York: McGraw- Hill Companies, Inc., 2014

Daniel T. Halperin, PhD Gillings School of Global Public Health, University of North Carolina at Chapel Hill

San Francisco, California
Infectious Diseases, Public Health - Covid-19, Covid vaccines, Epidemiology, HIV, AIDS, Masks, Prevention, Pandemics
Daniel Halperin is an internationally recognized expert in public health and infectious diseases, specializing in HIV-AIDS and Covid-19. Dr. Halperin has taught and conducted research on the faculties of the University of California, San Francisco and Harvard University. He has published over 10 articles on Covid-19, including several in the Washington Post and the Wall Street Journal, and is author of the highly regarded book, "Facing Covid Without Panic." He has served as an expert witness in litigation involving masking and other restrictions and COVID-19 vaccines, including regarding vaccine-related injuries and explaining the lack of scientific evidence to currently justify mandating that children be vaccinated against Covid-19. Reviews: “Dr. Halperin supported our legal team by providing great testimony and giving invaluable help in preparing to question the opposing expert. He was professional and helped to clarify weaknesses and potential landmines in our case. I cannot re...

D. Tyler Coyle, MD, MS Deedot Consulting LLC

Denver, Colorado
Addiction Medicine, Preventive Medicine - Epidemiology, Pharmacoepidemiology, Opioid Use Disorder, Methadone, Buprenorphine, Naltrexone, Addiction Medicine, Medical Education, Post-Marketing Safety Studies, Ivy League
Double board-certified in both Addiction Medicine and Public Health & General Preventive Medicine; tenure track at CU School of Medicine with joint appointment in the Colorado School of Public Health. Master’s degree in Epidemiology. After residency I worked as a medical pharmacoepidemiologist at the FDA for 3 years, specializing in the epidemiology of non-medical drug use — particularly opioids. My interests in drug safety and controlled substances led me to working in addiction medicine. I have served as the Assistant Medical Director for the opioid treatment program (I.e. methadone clinic) housed within the CU School of Medicine since 2020. I am the PI for a SAMHSA grant to provide addiction education to students in the MD, NP, and PA degree programs at CU. I am also the Program Director for the CU Preventive Medicine Residency where I serve on the GME Education Subcommittee. Expertise in communication to both medical and non-medical audiences; writing; interpersonal skills; ...

Syed A. Shah, MD, MPH, MBA Southern Tier Cardiology, PLLC

Penfield, New York
Cardiovascular Disease - MPH - Epidemiology, Management

Paul M. Lantos, MD, MS Duke University

Durham, North Carolina
Pediatric Infectious Diseases - Lyme disease, COVID / Coronavirus, malaria, typhoid, Rocky Mountain spotted fever, ehrlichiosis, tick-borne diseases, parasites, measles, pertussis, cytomegalovirus, infected animal bites, vaccines, travel medicine, epidemiology
• Triple-boarded specialist in Pediatric Infectious Diseases, Pediatrics, and Internal Medicine • Fellowship trained at Harvard Medical School, Boston Children's Hospital, and the Harvard School of Public Health • COVID-19 experience, including case management, test interpretation, isolation and public health recommendations, personal and occupational protective measures, risk assessments for adults and children at risk of severe COVID-19, and return to work determinations for infected employees. • Clinical and academic expertise in vector-borne infectious diseases (e.g. infections carried by ticks and mosquitoes), zoonotic infections (transmitted from animals, e.g. rabies, bartonella, cat scratch and cat bite fever), and environmental infectious diseases. • Clinical and academic expertise in geographic and travel medicine, including clinical malaria and malaria prevention, travel vaccines, pre-travel counseling and risk assessments, post-travel evaluation, prevention and treat...

Eileen E. Ming, MPH, ScD, FISPE Epi Excellence LLC

Garnet Valley, Pennsylvania
Public Health, Pharmaceutical Research - epidemiology, pharmacoepidemiology, outcomes research, observational research, real world evidence
Eileen E. Ming, MPH, ScD, FISPE, is an epidemiologist, pharmacoepidemiologist, outcomes researcher, and leader in the pharmaceutical industry. She served as an outcomes researcher at Merck, an epidemiologist at AstraZeneca, and the head of global epidemiology and pharmacoepidemiology at Shire Pharmaceuticals. Dr. Ming founded Epi Excellence, an epidemiology consulting practice, in 2014. She has worked across a variety of therapeutic areas, from pre-clinical through post-marketing phases, providing epidemiologic strategic and tactical expertise to commercial, clinical development, market access, medical affairs, regulatory, and pharmacovigilance activities. Dr. Ming is an Adjunct Scholar of the Center for Clinical Epidemiology and Biostatistics, and an Adjunct Investigator of the Center for Pharmacoepidemiology Research and Training, at the Perelman School of Medicine at the University of Pennsylvania. She is a Fellow of the International Society for Pharmacoepidemiology. Dr. Ming r...

Theron Blickenstaff, MD, FACOEM Occupational and Environmental Medicine Consulting

Kingsport, Tennessee
Occupational Medicine, Toxicology - Epidemiology, Cancer causation, Indoor Air Quality, Inhalation exposure, Chemical exposure, Occupational Lung Disease, Material Safety Data Sheets, Medical Record Reviews, Disability Consultation
Review of records, written reports, affidavits, depositions, courtroom testimony. Workers Compensation, Social Security Disability. Occupational exposures, environmental exposures, consumer product exposures. Defense and plaintiff. Over 20 years experience in occupational and environmental medicine. Material Safety Data Sheets. Exposure assessment a particular strength.

Remington Nevin, MD, MPH, DrPH Office of Dr. Remington Nevin

White River Junction, Vermont
Occupational Medicine, Preventive Medicine - Occupational Medicine, Public Health and General Preventive Medicine, Epidemiology, Pharmacoepidemiology and Drug Safety, Antimalarial Drug Adverse Effects, Antimalarial Drug Toxicity
Dr. Remington Nevin is a Vermont-based physician epidemiologist and expert consultant in the adverse effects of antimalarial drugs, including mefloquine, tafenoquine, chloroquine, and hydroxychloroquine. Dr. Nevin has been invited to testify before the U.S. Senate, the Australian Senate, the U.K. Parliament, and the Canadian Parliament, and has provided evidence to the Irish Department of Defence. Dr. Nevin’s work has been instrumental in improving policymakers’ understanding of the potential for long-lasting and permanent neurologic and psychiatric effects from quinoline antimalarials. Dr. Nevin's work has also contributed directly to militaries in the U.S., Canada, the U.K., and Ireland discontinuing their decades-long policies of first-line use of mefloquine, in favor of safer and better-tolerated alternatives. Dr. Nevin was first to publish a clinical description of quinism, the permanent disorder of brain and brainstem dysfunction caused by the use of mefloquine and related q...